These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 28671770

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P, Rosso E, Fuchshuber P, Oussoultzoglou E, De Blasi V, Simone G, Belletier C, Dufour P, Bachellier P.
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [Abstract] [Full Text] [Related]

  • 6. Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review.
    Butturini G, Pisano M, Scarpa A, D'Onofrio M, Auriemma A, Bassi C.
    Langenbecks Arch Surg; 2011 Mar; 396(3):363-9. PubMed ID: 20803029
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
    Lovecek M, Skalicky P, Chudacek J, Szkorupa M, Svebisova H, Lemstrova R, Ehrmann J, Melichar B, Yogeswara T, Klos D, Vrba R, Havlik R, Mohelnikova-Duchonova B.
    World J Gastroenterol; 2017 Sep 21; 23(35):6420-6428. PubMed ID: 29085191
    [Abstract] [Full Text] [Related]

  • 9. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB, Rocha FG, Alseidi A, Biehl T, Moonka R, Ryan JA, Lin B, Picozzi V, Helton S.
    Ann Surg Oncol; 2014 May 21; 21(5):1530-7. PubMed ID: 24473642
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case report.
    Schempf U, Sipos B, König C, Malek NP, Bitzer M, Plentz RR.
    Z Gastroenterol; 2014 Feb 21; 52(2):200-3. PubMed ID: 24526405
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pancreatic acinar cell carcinoma: a multi-institutional study.
    Matos JM, Schmidt CM, Turrini O, Agaram NP, Niedergethmann M, Saeger HD, Merchant N, Johnson CS, Lillemoe KD, Grützmann R.
    J Gastrointest Surg; 2009 Aug 21; 13(8):1495-502. PubMed ID: 19495891
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Presentation and outcome of mixed neuroendocrine non-neuroendocrine neoplasms of the pancreas.
    Nießen A, Schimmack S, Weber TF, Mayer P, Bergmann F, Hinz U, Büchler MW, Strobel O.
    Pancreatology; 2021 Jan 21; 21(1):224-235. PubMed ID: 33309225
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.